Meeting
2022 ASCO Annual Meeting
Early detection of colorectal adenocarcinoma by decoding epigenetic and DNA fragmentation fingerprints of plasma cell-free DNA.
Authors
Li Suxing
Genecast Biotechnology Co., Ltd., Wuxi, China
Li Suxing , Tiancheng Han , Shunli Yang , Dan Liu , Peiyao Nie , Fang Lv , Shuying He , Ying Yang , Yulong LI , Jianing Yu , Yuanyuan Hong , Yu S. Huang , Weizhi Chen , Zhengqi Wen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3550)
DOI
10.1200/JCO.2022.40.16_suppl.3550
Abstract #
3550
Poster Bd #
344
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Non-invasive detection of esophageal carcinoma by integrative analysis of low-pass whole methylome sequencing of plasma cell-free DNA.
First Author: Dan Liu
Poster
2024 ASCO Annual Meeting
Leveraging cfDNA fragmentomic features in a stacked ensemble model for early detection of esophageal squamous cell carcinoma.
First Author: Zichen Jiao
Poster
2021 ASCO Annual Meeting
Detection of cancer signal for over 50 AJCC cancer types with a multi-cancer early-detection test.
First Author: Habte Aragaw Yimer
Poster
2024 ASCO Breakthrough
Analysis of heterochromatin remodeling as a mechanism of radiotherapy (RT) resistance through molecular profiling of radioresistant (RR) head and neck (HNC) and prostate cancers (PCa).
First Author: Evelyn Tan